These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32539490)

  • 21. Genetic Diversity, Complicated Recombination, and Deteriorating Drug Resistance Among HIV-1-Infected Individuals in Wuhan, China.
    Zhang Y; Luo Y; Li Y; Zhang Y; Wu W; Peng H; Han L; Chen Y; Ruan L; Yang R
    AIDS Res Hum Retroviruses; 2021 Mar; 37(3):246-251. PubMed ID: 32878449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China.
    Chen M; Ma Y; Duan S; Xing H; Yao S; Su Y; Luo H; Yang L; Chen H; Fu L; Qu A; Ou CY; Jia M; Lu L
    BMC Infect Dis; 2012 Dec; 12():382. PubMed ID: 23270497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.
    Zhang M; Ma Y; Wang Z; Wang G; Wang Q; Li X; Lin F; Zhang C
    Virulence; 2024 Dec; 15(1):2373105. PubMed ID: 38934465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.
    Gao L; Xia H; Zeng R; Wu Y; Zaongo SD; Hu Y; Ma P
    HIV Med; 2022 Mar; 23 Suppl 1():84-94. PubMed ID: 35293099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
    Liang S; Liu Z; Wang S; Liu J; Shi L; Mao W; Liu C; Wan J; Zhu L; Huang M; Liu Y; Wang J; Ness P; Shan H; Zeng P; He M
    PLoS One; 2020; 15(12):e0243650. PubMed ID: 33347449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
    Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
    BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.
    Kiros M; Biset S; Gebremariam B; Yalew GT; Abegaz WE; Geteneh A
    Virol J; 2023 Oct; 20(1):243. PubMed ID: 37880705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic Subtypes and Pretreatment Drug Resistance in the Newly Reported Human Immunodeficiency Virus-Infected Men Aged≥50 Years Old in Guangxi].
    Fang NY; Wei WC; Li JJ; Cen P; Feng XX; Yang D; Tang KL; Liang SJ; Shao YL; Lu HX; Jiang H; Meng Q; Liu SF; Zhu QY; Chen HH; Lan GH; Yang SX; Zhou LF; Mo JL; Ge XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):399-404. PubMed ID: 37407525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016-2023).
    Gao W; Zhou G; Li M; Wang P; Li J; Deng R
    AIDS Res Ther; 2024 Sep; 21(1):62. PubMed ID: 39272106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of HIV-1 molecular transmission networks and drug resistance among men who have sex with men in Tianjin, China (2014-2018).
    Zheng M; Yu M; Cheng S; Zhou N; Ning T; Li L; Zhao F; Zhao X; Zhu J; Jiang G
    Virol J; 2020 Nov; 17(1):169. PubMed ID: 33143744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
    Wang Z; Jiang H; Pang X; Li J; Liang S; Huang J; Li D; Hou W; Chen N; Lan G
    J Antimicrob Chemother; 2024 Oct; 79(10):2575-2585. PubMed ID: 39045823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Rate of HIV-1 Drug Resistance in Antiretroviral Therapy-Failure Patients in Liaoning Province, China.
    Wei Q; Zhao Y; Lv Y; Kang X; Pan S; Yao S; Wang L
    AIDS Res Hum Retroviruses; 2022 Jun; 38(6):502-509. PubMed ID: 35229630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017].
    Zheng MN; Ning TL; Zhou N; Zhao X; Li L; Zhu JJ; Cheng SH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):619-624. PubMed ID: 29860805
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.
    Trebelcock WL; Lama JR; Duerr A; Sanchez H; Cabello R; Gilada T; Segura P; Reisner SL; Mayer KH; Mullins J; Bender Ignacio RA
    J Int AIDS Soc; 2019 Nov; 22(11):e25411. PubMed ID: 31773888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
    Chen GJ; Cheng CY; Yang CJ; Lee NY; Tang HJ; Huang SH; Huang MH; Liou BH; Lee YC; Lin CY; Hung TC; Lin SP; Sun HY; Chang SY; Hung CC;
    J Antimicrob Chemother; 2024 May; 79(5):1157-1163. PubMed ID: 38546761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.
    Chen J; Liu Y; Liu S; Yuan D; Su L; Ye L; Gong F; Gao Y; Baloch S; Pei X
    Biomed Res Int; 2020; 2020():5894124. PubMed ID: 32280691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characterization and antiretroviral resistance mutations among treatment-naive HIV-infected individuals in Jiaxing, China.
    Guo J; Yan Y; Zhang J; Ji J; Ge Z; Ge R; Zhang X; Wang H; Chen Z; Luo J
    Oncotarget; 2017 Mar; 8(11):18271-18279. PubMed ID: 28407682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010-2016.
    Dong K; Ye L; Leng Y; Liang S; Feng L; Yang H; Su L; Li Y; Baloch S; He F; Yuan D; Pei X
    Tohoku J Exp Med; 2019 Jan; 247(1):1-12. PubMed ID: 30643108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
    Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
    PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic Subtypes and Status of Transmitted Drug Resistance of HIV/AIDS Patients in Sichuan].
    Liu HX; He SH; Zhou RF; He YH; Yang TT; Yao Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):851-856. PubMed ID: 36224688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.